Clinical trial focus: Developing JKB-122 as a new treatment for autoimmune hepatitis – principles and future directions
In this clinical trial focus, the authors discuss difficult-to-treat patients with autoimmune hepatitis, and the potential of additional treatment option JKB-122.
